The Development of Endoxifen for Breast Cancer

Autor Goetz, Matthew P.
Vydáno v Clin Adv Hematol Oncol (2018)

Landscape of Neoadjuvant Therapy for Breast Cancer

Autor Haddad, Tufia C., Goetz, Matthew P.
Vydáno v Ann Surg Oncol (2015)

Multidisciplinary Management of Breast Cancer With Extensive Regional Nodal Involvement

Autor Smith, Benjamin D., Goetz, Matthew P., Boughey, Judy C.
Vydáno v J Clin Oncol (2020)

The emerging role of CDK4/6i in HER2-positive breast cancer

Autor O’Sullivan, Ciara C., Suman, Vera J., Goetz, Matthew P.
Vydáno v Ther Adv Med Oncol (2019)

Synergistic interactions between aminoflavone, paclitaxel and camptothecin in human breast cancer cells

Autor Reinicke, Kathryn E., Kuflel, Mary J., Goetz, Matthew P., Ames, Matthew M.
Vydáno 2009

Clinical implementation of pharmacogenomics: overcoming genetic exceptionalism

Autor Relling, Mary V., Altman, Russ B., Goetz, Matthew P., Evans, William E.
Vydáno v Lancet Oncol (2010)

Tamoxifen Metabolism and Breast Cancer Recurrence: A Question Unanswered by CYPTAM

Autor Goetz, Matthew P., Suman, Vera J., Nakamura, Yusuke, Kiyotani, Kazuma, Jordan, V. Craig, Ingle, James N.
Vydáno v J Clin Oncol (2019)

Pregnancy-Associated Plasma Protein-A Expression in Human Breast Cancer

Autor Mansfield, Aaron S., Visscher, Daniel W., Hart, Steven N., Wang, Chen, Goetz, Matthew P., Oxvig, Claus, Conover, Cheryl A.
Vydáno v Growth Horm IGF Res (2014)

Re: Concordance Between CYP2D6 Genotypes Obtained From Tumor-Derived and Germline DNA

Autor Goetz, Matthew P., Brauch, Hiltrud, Ratain, Mark J., Cox, Nancy J., Nakamura, Yusuke, Weinshilboum, Richard, Ingle, James N.
Vydáno v J Natl Cancer Inst (2014)

Use of 21-gene recurrence score assay to individualize adjuvant chemotherapy recommendations in ER+/HER2− node positive breast cancer—A National Cancer Database study

Autor Peethambaram, Prema P., Hoskin, Tanya L., Day, Courtney N., Goetz, Matthew P., Habermann, Elizabeth B., Boughey, Judy C.
Vydáno v NPJ Breast Cancer (2017)

Tamoxifen Use in Postmenopausal Breast Cancer: CYP2D6 Matters

Autor Brauch, Hiltrud, Schroth, Werner, Goetz, Matthew P., Mürdter, Thomas E., Winter, Stefan, Ingle, James N., Schwab, Matthias, Eichelbaum, Michel
Vydáno 2013

Development and characterization of novel endoxifen-resistant breast cancer cell lines highlight numerous differences from tamoxifen-resistant models

Autor Jones, Calley J., Subramaniam, Malayannan, Emch, Michael J., Bruinsma, Elizabeth S., Ingle, James N., Goetz, Matthew P., Hawse, John R.
Vydáno v Mol Cancer Res (2021)

Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo

Autor Khurana, Ashwani, McKean, Hiedi, Kim, Hyunseok, Kim, Sung-Hoon, Mcguire, Jacie, Roberts, Lewis R, Goetz, Matthew P, Shridhar, Viji
Vydáno 2012

Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy

Autor Al-Hilli, Zahraa, Choong, Grace, Keeney, Michael G., Visscher, Daniel W., Ingle, James N., Goetz, Matthew P., Jakub, James W.
Vydáno v Breast Cancer Res Treat (2019)

Baseline estrogen levels in postmenopausal women participating in the MAP.3 breast cancer chemoprevention trial

Autor Richardson, Harriet, Ho, Vikki, Pasquet, Romain, Singh, Ravinder J., Goetz, Matthew P., Tu, Dongsheng, Goss, Paul E., Ingle, James N.
Vydáno v Menopause (2020)

MRI Radiomics for Assessment of Molecular Subtype, Pathological Complete Response, and Residual Cancer Burden in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

Autor Choudhery, Sadia, Gomez-Cardona, Daniel, Favazza, Christopher P, Hoskin, Tanya L, Haddad, Tufia C, Goetz, Matthew P, Boughey, Judy C
Vydáno v Acad Radiol (2022)

Phase I study of panobinostat (LBH589) and letrozole in post-menopausal metastatic breast cancer patients

Autor Tan, Winston W., Allred, Jacob B., Moreno-Aspitia, Alvaro, Northfelt, Donald W., Ingle, James N., Goetz, Matthew P., Perez, Edith A.
Vydáno v Clin Breast Cancer (2015)

Phase I trial to evaluate the addition of alisertib to fulvestrant in women with endocrine-resistant, ER+ metastatic breast cancer

Autor Haddad, Tufia C., D’Assoro, Antonino, Suman, Vera, Opyrchal, Mateusz, Peethambaram, Prema, Liu, Minetta C., Goetz, Matthew P., Ingle, James N.
Vydáno v Breast Cancer Res Treat (2017)

The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1

Autor Cairns, Junmei, Ingle, James N., Kalari, Krishna R., Shepherd, Lois E., Kubo, Michiaki, Goetz, Matthew P., Weinshilboum, Richard M., Wang, Liewei
Vydáno v Breast Cancer Res (2019)

CYP2D6 genotype and tamoxifen response

Autor Rae, James M, Goetz, Matthew P, Hayes, Daniel F, Ingle, James N, Li, Lang, Storniolo, Anna Maria, Stearns, Vered, Flockhart, David A
Vydáno 2005